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Abstract
Background: Hepatotoxicity is a form of liver injury caused by exposure to stressors. Genomic-
based approaches have been used to detect changes in transcription in response to
hepatotoxicants. However, there are no straightforward ways of using co-expressed genes
anchored to a phenotype or constrained by the experimental design for discerning mechanisms of
a biological response.
Results: Through the analysis of a gene expression dataset containing 318 liver samples from rats
exposed to hepatotoxicants and leveraging alanine aminotransferase (ALT), a serum enzyme
indicative of liver injury as the phenotypic marker, we identified biological processes and molecular
pathways that may be associated with mechanisms of hepatotoxicity. Our analysis used an approach
called Coherent Co-expression Biclustering (cc-Biclustering) for clustering a subset of genes
through a coherent (consistency) measure within each group of samples representing a subset of
experimental conditions. Supervised biclustering identified 87 genes co-expressed and correlated
with ALT in all the samples exposed to the chemicals. None of the over-represented pathways
related to liver injury. However, biclusters with subsets of samples exposed to one of the 7
hepatotoxicants, but not to a non-toxic isomer, contained co-expressed genes that represented
pathways related to a stress response. Unsupervised biclustering of the data resulted in 1) four to
five times more genes within the bicluster containing all the samples exposed to the chemicals, 2)
biclusters with co-expression of genes that discerned 1,4 dichlorobenzene (a non-toxic isomer at
low and mid doses) from the other chemicals, pathways and biological processes that underlie liver
injury and 3) a bicluster with genes up-regulated in an early response to toxic exposure.
Conclusion:  We obtained clusters of co-expressed genes that over-represented biological
processes and molecular pathways related to hepatotoxicity in the rat. The mechanisms involved
in the response of the liver to the exposure to 1,4-dichlorobenzene suggest non-genotoxicity
whereas the exposure to the hepatotoxicants could be DNA damaging leading to overall genomic
instability and activation of cell cycle check point signaling. In addition, key pathways and biological
processes representative of an inflammatory response, energy production and apoptosis were
impacted by the hepatotoxicant exposures that manifested liver injury in the rat.
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Background
The liver is considered one of the vital organs in the body.
Its has several major functions including the production
of bile to break down fat, glycogen storage, decomposi-
tion of red blood cells, production of cholesterol, plasma
protein synthesis and drug metabolism just to name a few.
The latter takes place by a host of specialized detoxifica-
tion enzymes and pathways that biochemically modify or
metabolize xenobiotics to harmless metabolites and other
byproducts for clearance from the body [1]. However, the
metabolism of some drugs and compounds leads to toxic
intermediates that can harm the liver and severely disrupt
its function [2]. Drug-induced liver injury (DILI) is the
leading cause of liver failure in the United States (US) and
is quickly becoming a major concern world-wide [3]. In
fact, DILI accounts for more than 50 percent of the cases
of acute liver failure in the US and more than 75 percent
of cases of adverse drug reactions result in liver transplan-
tation or death [4]. Drug-induced hepatotoxicity is the
most frequent cause for a drug to be withdrawn from the
market, restricted in its use or have a warning associated
with it due to adverse drug reactions [5]. A better under-
standing of the pathophysiology of DILI and the mecha-
nisms involved in the manifestation of hepatotoxicity are
critical to improving human health and public awareness
of potentially harmful toxicants [6].
Microarray gene expression analysis has been used to
study the effects of toxicants and other environmental
stressors on biological systems [7-11]. Recently, Loben-
hofer et al. [12] used gene expression data from rats
exposed to a compendium of hepatotoxicants to show
that blood gene expression patterns could be used not
only to classify animals based on the compound they were
exposed to, but also to provide a reasonable indication of
the severity level of liver injury. In addition, Bushel et al.
[13] demonstrated that gene expression profiles from rat
blood samples could accurately predict exposure levels of
acetaminophen to the rat liver better than traditional clin-
ical panels. Furthermore, human subjects treated with
acetaminophen could be classified based on blood gene
expression levels. Although these efforts led to informa-
tive conclusions about the genes expression changes
related to drug-induced hepatotoxicity, they did not cap-
ture the breath of the biological mechanisms altered by
the toxic insult.
While hierarchical clustering groups genes and samples by
the similarity of expression across all the elements in a
data matrix, biclustering [14-17] aims to identify sub-
matrices (subsets of rows [genes] and subsets of columns
[samples] from an original data matrix) of gene expres-
sion that are coherent and possess homogeneity of co-
expression. Hence, the biclusters contain co-expressed
genes that represent distinct biological responses related
to mechanistic changes. In this paper we used a bicluster-
ing method to analyze a compendium gene expression
dataset containing 318 liver samples from rats exposed to
hepatotoxicants (in a dose response and time series man-
ner) and leveraged alanine aminotransferase (ALT), a
serum enzyme indicative of liver injury, as the phenotypic
marker in order to identify biclusters of co-expressed
genes that over-represent biological processes and path-
ways related to hepatotoxicity.
Results
Experimental design
Male 12 week old F344 Fischer rats were exposed to one
of the following chemicals: 1,2-dichlorobenzene, 1,4-
dichlorobenzene, bromobenzene, monocrotaline, N-
nitrosomorpholine, thioacetamide, galactosamine or
diquat dibromide [12]. For each chemical, four to six rats
(two in one case), were exposed to three or four different
dose levels (from subtoxic to toxic) of the compound and
sacrificed at 6, 24 and 48 hrs later to extract liver RNA for
microarray hybridization. The 318 samples and exposure
conditions are listed in Table 1. The number of samples in
each group varied from 32 to 72. Liver necrosis was
observed in all the rats exposed to one of the eight chem-
icals at high doses (Table 2). However, 1,4-dichloroben-
zene is an isomer of 1,2-dichlorobenzene and is non-toxic
at low and mid doses. Since each compound has its
unique chemical structure and properties, the activated
biological processes, molecular pathways, extent of toxic-
ity in the liver and injury could be highly similar or dis-
similar. Considering these variables, we partitioned the
columns of the gene expression data matrix into eight
groups (one for each chemical) for analysis using Coher-
ent Co-expression (cc)-Biclustering.
Identification of co-expressed genes based on ALT enzyme 
levels
Each group of chemicals included a set of samples with
different exposure conditions (different doses and time
points). We used ALT as a profile to supervise the extrac-
tion of the genes that are expressed similarly and corre-
lated with the phenotypic marker. ALT values in each of
the chemical exposures were generally elevated from 6,
24, to 48 hrs and from low doses to high doses. For a
probability threshold (pt) value of 0.001, supervised cc-
Biclustering extracted 84 biclusters in which the genes
were correlated (r-value >= 0) to ALT and 76 biclusters in
which the genes were anti-correlated (r-value < 0) to ALT.
The number of genes in each bicluster varied. The largest
number of genes in a bicluster was 713. The number of
groups (chemicals) in the biclusters had a range from a
minimum of 1 to a maximum of 8. The biclusters which
contained only one chemical could represent the unique-
ness in gene expression for the agent and the biclusters
which contained all eight chemicals could provide someBMC Genomics 2009, 10:272 http://www.biomedcentral.com/1471-2164/10/272
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clues to the common responses to the exposures across
the agents.
Figure 1 displays heat maps of two biclusters which
included all eight groups of chemicals. There are 87 genes
in Figure 1A (the top half) and 86 genes in Figure 1B (the
bottom half) significantly correlated and anti-correlated
to the ALT profile, respectively. From Gene Ontology
analysis of the genes in the biclusters, it was revealed that
the significantly over-represented KEGG pathways and
biological processes that are up-regulated included gen-
eral mechanisms such as translation and biosynthetic
processes from the genes correlated with ALT and down-
regulated categories such as response to external stimuli,
negative regulation of coagulation and macromolecule
metabolism/biosynthesis from the anti-correlated genes
(Table 3). It is interesting that none of the over-repre-
sented categories appeared to be related to liver injury.
Figure 2 shows heat maps of two biclusters which con-
sisted of seven groups of chemicals not including 1,4-
dichlorobenzene. There are 182 genes correlated to the
ALT profile in Figure 2A (the top half) and 76 anti-corre-
lated genes in Figure 2B (the bottom half). Gene Ontology
analysis revealed that over-represented KEGG pathways
and biological processes included a defense response,
wound healing, cell proliferation and hematopoietic
migration from the genes correlated with ALT and catego-
Table 1: The eight chemical compounds in the compendium
Compound (total number of samples) Dose (mg/kg body weight) Time (hour) (number of replicates)
1,2-dichlorobenzene (34) 15 6 (4) 24 (4) 48 (4)
150 6 (4) 24 (4) 48 (4)
1500 6 (4) 24 (4) 48 (2)
1,4-dichlorobenzene (36) 15 6 (4) 24 (4) 48 (4)
150 6 (4) 24 (4) 48 (4)
1500 6 (4) 24 (4) 48 (4)
Bromobenzene (36) 25 6 (4) 24 (4) 48 (4)
75 6 (4) 24 (4) 48 (4)
250 6 (4) 24 (4) 48 (4)
Diquat (72) 5 6 (6) 24 (6) 48 (6)
10 6 (6) 24 (6) 48 (6)
20 6 (6) 24 (6) 48 (6)
25 6 (6) 24 (6) 48 (6)
Galactosamine (36) 25 6 (4) 24 (4) 48 (4)
100 6 (4) 24 (4) 48 (4)
400 6 (4) 24 (4) 48 (4)
Monocrotaline (32) 10 6 (4) 24 (4) 48 (4)
50 6 (4) 24 (4) 48 (4)
300 6 (4) 24 (4)
N-nitrosomorpholine (36) 10 6 (4) 24 (4) 48 (4)
50 6 (4) 24 (4) 48 (4)
300 6 (4) 24 (4) 48 (4)
Thioacetamide (36) 15 6 (4) 24 (4) 48 (4)
50 6 (4) 24 (4) 48 (4)
150 6 (4) 24 (4) 48 (4)
Table 2: Percent of necrosis of the hepatocytes
% of hepatocytes showing necrosis
Chemical No Sign <5% 5%–25% 26%–50% >50%
1,2-dichlorobenzene 17 8 5 2 2
1,4-dichlorobenzene 31 4 1 0 0
bromobenzene 16 7 5 0 8
diquat 50 10 6 4 2
galactosamine 18 7 8 2 1
monocrotaline 16 11 1 0 4
N-nitrosomorpholine 12 17 2 1 4
thioacetamide 4 18 1 6 7
Total sample size 164 82 29 15 28BMC Genomics 2009, 10:272 http://www.biomedcentral.com/1471-2164/10/272
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ries related to lipid and steroid metabolism as well as the
alkylation of amino acids, tryptophan and sulfur metabo-
lism from the anti-correlated genes (Table 4).
The Gene Ontology analysis of three biclusters from two
chemicals, galactosamine and thioacetamide, revealed
interesting categorization of the genes (see Additional file
1 Figure S1 and Table S1). The 401 genes in a bicluster
subset by galactosamine over-represented a KEGG path-
way related to extracellular matrix (ECM) receptor interac-
tion (Figure S1A). Another bicluster of 364 genes subset
by thioacetamide had a different set of significantly over-
represented categories representing the Wnt signalling
pathway and glycerophospholipid metabolism (Figure
S1B). The third bicluster of 289 genes subset by both
chemicals had biological processes and KEGG pathways
related to neuron development and cell adhesion as over-
represented categories (Figure S1C).
Identification of co-expressed genes that discern isomers 
and an early response
Although the blood serum level of ALT is a good indicator
of liver injury, it is not considered a prognosticator of
toxic insult as the true nature and extent of the liver dam-
age is not proportional to the elevation in the serum
enzyme activity [18]. For instance, a normal ALT level
does not necessarily mean that the liver is definitely nor-
mal and high levels of ALT in the blood doesn't necessar-
ily indicate the extent to which the liver is inflamed or
damaged. In addition, it is likely that ALT levels elevate
well after the mechanistic changes have occurred that led
to the liver injury from toxic exposure. Therefore, we set
out to use cc-Biclustering in an unsupervised fashion
(without ALT) so we could find biclusters of genes that
may be unrelated to ALT or respond before ALT elevation
and yet are very informative in terms of the manifestation
of hepatotoxicity. We obtained more biclusters (~ three
times more) using unsupervised cc-Biclustering when the
same threshold pt was used as in the supervised case.
Similar to the biclusters in Figure 1, the genes in the heat
maps shown in Figure 3 are subset by all eight chemicals.
There are 330 genes up-regulated as shown in Figure 3A
(the top half) and 409 down-regulated genes as shown in
Figure 3B (the bottom half). Compared to the number of
genes in the bicluster shown in Figure 1, the bicluster in
Figure 3 contained about four to five times more genes
and more significant categories (Table 5). The set of genes
that are up-regulated were found to over-represent biolog-
ical processes and KEGG pathways representative of a
more toxic response (i.e. less similar to the general
responses over-represented by the genes in the bicluster
from the supervised clustering [Figure 1A]). Apoptosis, an
inflammatory response and glycolysis/gluconeogenesis
Table 3: Significant biological processes and pathways of a general response across all chemicals
Identifier Term p-value
Correlated with ALT
GO:0006412 translation 4.45E-04
GO:0044249 cellular biosynthetic process 2.10E-03
GO:0006414 translational elongation 4.31E-03
GO:0006935 chemotaxis 4.99E-03
GO:0022613 ribonucleoprotein complex biogenesis and assembly 4.99E-03
GO:0009058 biosynthetic process 9.04E-03
GO:0009059 macromolecule biosynthetic process 9.27E-03
rno03010 Ribosome 1.55E-06
Anti-correlated with ALT
GO:0006725 aromatic compound metabolic process 1.43E-04
GO:0006519 amino acid and derivative metabolic process 2.13E-04
GO:0050878 regulation of body fluid levels 1.07E-03
GO:0019752 carboxylic acid metabolic process 1.16E-03
GO:0006790 sulfur metabolic process 1.50E-03
GO:0009605 response to external stimulus 2.81E-03
GO:0050819 negative regulation of coagulation 4.87E-03
GO:0006091 generation of precursor metabolites and energy 6.25E-03
GO:0009309 amine biosynthetic process 9.18E-03
rno01040 Polyunsaturated fatty acid biosynthesis 7.97E-03
rno04610 Complement and coagulation cascades 1.27E-02
rno00410 beta-Alanine metabolism 1.41E-02
rno00770 Pantothenate and CoA biosynthesis 7.85E-02BMC Genomics 2009, 10:272 http://www.biomedcentral.com/1471-2164/10/272
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were key mechanisms impacted. The set of down-regu-
lated genes contained over-represented categories related
to cholesterol biosynthesis, fatty acid metabolism, alka-
loid biosynthesis and the peroxisome proliferator-acti-
vated receptors (PPARs) signaling pathway. PPAR-α is
mainly expressed in the liver and activation of the receptor
has been associated with suppression of apoptosis and
induction of cell proliferation [19].
Heat maps of the gene expression from three biclusters
subset by seven chemicals (excluding 1,4-dichloroben-
zene), are shown in Figure 4. Figure 4A (the top) shows
175 co-expressed genes up-regulated at a later time and
Figure 4B (the middle) 114 co-expressed genes down-reg-
ulated. The set of up-regulated genes significantly over-
represented categories that are suggestive of liver regener-
ation (Table 6) [20,21]. Angiogenesis, the regulation of
actin cytoskeleton, regulation of adherens (adhesion)
junctions and the Toll-like receptor (TLR) signaling path-
way were impacted. The down-regulated genes over-repre-
sented mechanisms related to energy producing pathways
(glucose homeostasis, gluconeogenesis and the pentose
phosphate pathways). Comparisons of the over-repre-
sented categories between the genes in Figure 3 and 4
clearly differentiate 1,4-dichlorobenzene from the other
chemicals since the biclusters in Figure 4 do not contain
genes that are co-expressed in the samples exposed to 1,4-
dichlorobenzene. Figure 4C (the bottom) had 47 genes
Table 4: Significant biological processes and pathways from the hepatotoxicant exposures
Identifier Term p-value
Correlated with ALT
GO:0006952 defense response 1.15E-04
GO:0006928 cell motility 8.31E-04
GO:0048519 negative regulation of biological process 1.09E-03
GO:0009605 response to external stimulus 1.17E-03
GO:0018108 peptidyl-tyrosine phosphorylation 1.41E-03
GO:0050819 negative regulation of coagulation 1.46E-03
GO:0018212 peptidyl-tyrosine modification 1.69E-03
GO:0032496 response to lipopolysaccharide 1.80E-03
GO:0007626 locomotory behavior 1.95E-03
GO:0007599 hemostasis 2.01E-03
GO:0008283 cell proliferation 2.05E-03
GO:0009611 response to wounding 2.06E-03
GO:0051707 response to other organism 2.15E-03
GO:0050818 regulation of coagulation 2.19E-03
GO:0002237 response to molecule of bacterial origin 2.19E-03
GO:0051246 regulation of protein metabolic process 3.64E-03
GO:0042127 regulation of cell proliferation 3.91E-03
GO:0065008 regulation of biological quality 5.76E-03
GO:0032501 multicellular organismal process 6.25E-03
GO:0008284 positive regulation of cell proliferation 7.11E-03
GO:0048523 negative regulation of cellular process 7.16E-03
GO:0007596 blood coagulation 8.27E-03
GO:0050789 regulation of biological process 8.48E-03
GO:0050878 regulation of body fluid levels 8.96E-03
GO:0009617 response to bacterium 9.56E-03
GO:0009607 response to biotic stimulus 1.08E-02
rno04640 Hematopoietic cell lineage 3.00E-02
rno04670 Leukocyte transendothelial migration 6.96E-02
Anti-correlated with ALT
GO:0006629 lipid metabolic process 7.39E-04
GO:0032787 monocarboxylic acid metabolic process 5.01E-03
GO:0008202 steroid metabolic process 5.10E-03
GO:0008152 metabolic process 7.68E-03
GO:0042221 response to chemical stimulus 7.86E-03
rno00960 Alkaloid biosynthesis II 2.18E-03
rno00380 Tryptophan metabolism 1.92E-02
rno00920 Sulfur metabolism 4.53E-02BMC Genomics 2009, 10:272 http://www.biomedcentral.com/1471-2164/10/272
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up-regulated early and significantly over-represented cate-
gories pointing to a negative regulation of protein kinase
activity, the mitogen-activated protein kinase (MAPK) sig-
naling pathway, and apoptosis (Table 6).
Discussion and Conclusion
Over the recent years several ways of investigating drug-
induced hepatotoxicity has been explored. Using gene
expression analysis of samples exposed to toxicants offers
a genome-wide assessment of the transcriptional changes
that occur from the insult. However, current methodolo-
gies for analyzing the data are limited in that they typically
do not "anchor" the changes in gene expression to the
phenotype of toxicity nor do they constrain them by the
experimental design. Case in point is hierarchical cluster-
ing of genes and samples based on gene expression data.
Although the method provides an overall view of the clus-
ters of genes that are co-expressed within a group of highly
similar samples, it does not extract subclusters of co-
expressed genes that are related to a given phenotype, end-
point measure of the samples or subset of experiments.
Yoon et al. [17] proposed a method for discovering coher-
ent biclusters from gene expression data using decision
diagrams constituted from binary representations of a set
of samples in which the expression of a subset of genes are
highly similar (coherent). However, the method does not
integrate phenotypic data nor is it guided by the experi-
mental design (i.e. constraints imposed by a time series or
dose response study). Linking co-expressed genes to a
phenotype of interest or set of experimental conditions
can potentially enhance the interpretation of the biologi-
cal systems that are impacted from the manifestation of an
outcome [22].
We analyzed a compendium gene expression dataset con-
taining 318 liver samples from rats exposed to hepatotox-
icants and leveraged alanine aminotransferase (ALT), a
serum enzyme indicative of liver injury as the phenotypic
marker, to identify several biological processes and molec-
ular pathways that may be associated with mechanisms of
hepatotoxicity. Our analysis used an approach to biclus-
tering called Coherent Co-expression Biclustering (cc-
Biclustering) for clustering of a subset of genes through a
coherent (consistency) measure within each group of
samples representing a subset of experimental conditions.
Existing biclustering methods use some measure of merit
to determine whether a row (gene) or column (sample)
should be included or excluded from a bicluster [23]. cc-
Biclustering uses a given coherent measure (CM) to deter-
mine whether a gene or a group of samples is included or
excluded from a bicluster. The CM used between pairs of
gene vectors (or gene vectors with a phenotypic profile) is
flexible. Depending on a research interest, CM can be cho-
sen to be Pearson correlation, Euclidean distance or some
other measure of (dis)similarity. Unsupervised cc-Biclus-
tering uses a pairwise comparison of the gene expression
profiles to extract biclusters. In the case of supervised cc-
Biclustering, we correlated the co-expression of the subset
of genes within a bicluster with ALT. The overlap between
the up-regulated genes from the supervised and unsuper-
vised cc-Biclustering methods is 61 genes (Additional file
1; Figure S2) where as the overlap between the down-reg-
ulated genes from the two methods is 78 genes (Addi-
tional file 1: Figure S3). The sharp contrast between
biclusters in Figure 1 and Figure 2 with respect to the over-
Heat maps of two biclusters containing samples from all  exposures and genes correlated with ALT Figure 1
Heat maps of two biclusters containing samples from 
all exposures and genes correlated with ALT. The red 
color indicates up-regulation and the green color down-regu-
lation. (A) 87 genes up-regulated in the top half and (B) 86 
genes down-regulated in the bottom half were significantly 
correlated and anti-correlated to the ALT profile respec-
tively. From left to right are (1) 1,2-dichlorobenzene, (2) 1,4-
dichlorobenzene, (3) bromobenzene, (4) diquat dibromide, 
(5) galactosamine, (6) monocrotaline, (7) N-nitrosomorpho-
line and (8) thioacetamide. Each chemical has its dose expo-
sure from low (left) to high (right). Each chemical dose has its 
time duration from 6 (left), 24 (middle), to 48 hrs (right).
Heat maps of two biclusters from samples exposed to hepa- totoxicants and genes correlated with ALT Figure 2
Heat maps of two biclusters from samples exposed 
to hepatotoxicants and genes correlated with ALT. 
(A) 182 genes up-regulated in the top half and (B) 76 genes 
down-regulated in the bottom half were significantly corre-
lated and anti-correlated to the ALT profile respectively. 
From left to right are (1) 1,2-dichlorobenzene, (3) bro-
mobenzene, (4) diquat dibromide, (5) galactosamine, (6) 
monocrotaline, (7) N-nitrosomorpholine and (8) thioaceta-
mide. Note that 1,4-dichlorobenzene was excluded from 
these two biclusters. The doses and time points have the 
same order as in Figure 1.BMC Genomics 2009, 10:272 http://www.biomedcentral.com/1471-2164/10/272
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represented biological categories exhibited by the genes
positively correlated with ALT clearly differentiated 1,4-
dichlorobenzene from the other seven chemicals. This
finding is consistent with a study to predict the levels of
necrosis in the rat liver using this same compendium of
hepatotoxicants [24]. It was shown that 1,4-dichloroben-
zene was the only chemical with an observed necrosis
contained in less than 25% of the hepatocytes (one sam-
ple was < 25%, 4 samples were < 5%, and 31 samples had
no sign of necrosis). All the other chemicals caused
observed necrosis in > 50% of the hepatocytes in one or
more of the exposed samples (Table 2). Moreover, a
bicluster with samples exposed to bromobenzene, diquat
dibromide, galactosamine, monocrotaline or N-nitro-
somorpholine and 12 genes (including Cd40, Casp8 and
Nr4a1) correlated with ALT and contained over-repre-
sented categories related to an inflammatory response,
glycolysis/gluconeogenesis and apoptosis (Data not
shown). These are biological processes known to be
involved in hepatotoxicity [24,25].
Table 5: Significant biological processes and pathways of a more toxic response
Identifier Term p-value
Up-regulated
GO:0002274 myeloid leukocyte activation 3.04E-05
GO:0002444 myeloid leukocyte mediated immunity 7.08E-05
GO:0045321 leukocyte activation 1.95E-04
GO:0002349 histamine production during acute inflammatory response 1.21E-03
GO:0001821 histamine secretion 1.21E-03
GO:0012502 induction of programmed cell death 1.54E-03
GO:0002532 production of molecular mediator of acute inflammatory response 2.39E-03
GO:0043067 regulation of programmed cell death 2.40E-03
GO:0051052 regulation of DNA metabolic process 2.95E-03
GO:0032496 response to lipopolysaccharide 3.11E-03
GO:0006626 protein targeting to mitochondrion 4.51E-03
GO:0019221 cytokine and chemokine mediated signaling pathway 5.78E-03
GO:0002443 leukocyte mediated immunity 6.19E-03
GO:0006935 chemotaxis 6.58E-03
GO:0006952 defense response 6.91E-03
GO:0043068 positive regulation of programmed cell death 9.83E-03
rno04670 Leukocyte transendothelial migration 2.50E-04
rno00450 Selenoamino acid metabolism 3.71E-02
rno04650 Natural killer cell mediated cytotoxicity 4.56E-02
rno00010 Glycolysis/Gluconeogenesis 7.89E-02
Down-regulated
GO:0006091 generation of precursor metabolites and energy 2.16E-10
GO:0008610 lipid biosynthetic process 2.28E-09
GO:0006695 cholesterol biosynthetic process 6.87E-07
GO:0008203 cholesterol metabolic process 3.62E-06
GO:0006631 fatty acid metabolic process 6.22E-06
GO:0044262 cellular carbohydrate metabolic process 4.21E-04
GO:0042221 response to chemical stimulus 7.85E-04
GO:0005975 carbohydrate metabolic process 8.15E-04
GO:0009896 positive regulation of catabolic process 1.05E-03
GO:0050818 regulation of coagulation 1.40E-03
GO:0007596 blood coagulation 2.68E-03
GO:0045819 positive regulation of glycogen catabolic process 3.03E-03
GO:0007599 hemostasis 3.71E-03
GO:0042493 response to drug 5.78E-03
GO:0002526 acute inflammatory response 8.75E-03
GO:0050819 negative regulation of coagulation 9.20E-03
rno01040 Polyunsaturated fatty acid biosynthesis 2.17E-05
rno04610 Complement and coagulation cascades 3.70E-05
rno00960 Alkaloid biosynthesis II 1.28E-02
rno03320 PPAR signaling pathway 2.31E-02
rno00071 Fatty acid metabolism 2.52E-02BMC Genomics 2009, 10:272 http://www.biomedcentral.com/1471-2164/10/272
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Comparison of the over-represented categories between
the genes in the biclusters shown in Figures 3 and 4 (both
from the unsupervised biclustering) also differentiate 1,4-
dichlorobenzene from the other chemicals quite well. In
addition, 47 genes in a bicluster were found to be up-reg-
ulated early in response to the hepatotoxicant exposure
(Figure 4C bottom) and significantly over-represented
categories related to negative regulation of protein kinase
activity, the MAPK signaling pathway, and apoptosis
(Table 6). Many genes in this set (Atf4, Trib3, Jun, Btg2,
Gadd45a, Gadd45b, Ddit3, Cdkn1a, Hmox1, Cdk9, Bag5
and Mcl1) have been extensively studied in terms of their
response to toxicants or other external stimuli [26-31].
Most of these genes are targets of p53 and cause DNA
damage. Our finding suggests that the liver injury caused
by 1,4-dichlorobenzene could be non-genotoxic while the
other toxicants could be genotoxic. This result is consist-
ent with the current finding that early responses of some
genes at 6 hr differentiate 1,4-dichlorobenzene from the
other seven more toxic chemicals where it is evident that
transcriptional regulation by Jun and TP53 leads to necro-
sis [24].
Although the data from each array is independently col-
lected, in a vast number of cases, many of the related bio-
logical samples are highly correlated. For example, some
samples are from the same tissue, or treated by the same
chemical, or a time series. Same samples are merely bio-
logical replicates. In our study we analyzed rat liver sam-
ples exposed to one of eight chemicals. Each of the
hepatotoxicants has its unique chemical structure and
causes different levels and extent of liver injury (Table 2).
The activated biological processes and molecular path-
ways can be highly similar or dissimilar. The gene sets
involved in responding to each of the hepatotoxicants can
overlap to a large extent or be somewhat unique. Using
our biclustering approach we were able to capitalize on
the experimental design and/or phenotypic measure to
discern possible mechanisms of hepatotoxicity through
the over-representation of pathways and biological proc-
esses determined by co-expressed genes in cc-Biclusters.
More work is underway to efficiently process the wealth of
biclusters extracted for a more informed interpretation of
the mechanistic changes that take place during the forma-
tion of hepatotoxicity.
Methods
Gene expression data
Male 12 week old F344 Fischer rats were individually
exposed to one of the following chemicals: 1,2-dichlo-
robenzene, 1,4-dichlorobenzene, bromobenzene,
monocrotaline, N-nitrosomorpholine, thioacetamide,
galactosamine or diquat dibromide. All eight chemicals
were studied using standardized procedures, i.e. a com-
mon array platform, experimental procedures and data
retrieving and analysis processes. For details of the exper-
imental design see Lobenhofer et al[12]. Briefly, for each
chemical, four to six male rats were exposed to a low dose,
mid dose(s) or a high dose of the chemical and sacrificed
at 6, 24 or 48 hrs later. At necropsy, the liver of the rats
were harvested for RNA extraction. A time-matched vehi-
cle control pool was made for each chemical by pooling
equal amounts of RNA from each of the control animals.
Each treated animal was hybridized against a time-
matched control pool to the Agilent Rat Oligonucleotide
Microarray with a dye-swap technical replicate. Fluores-
cence intensities were measured with an Agilent DNA
Microarray Scanner and processed with the Agilent Fea-
ture Extraction software version A.7.5.1 for bromoben-
zene and 1,2-dichlorobenzene arrays and version 8.1.1.1
for the others. See the header of the Agilent data files for
more details of the scanning and data acquisition hard-
ware and software parameters. The 318 samples and expo-
sure conditions are listed in Table 1. Liver necrosis was
observed in all the rats exposed to one of the eight chem-
icals at high doses. However, 1,4-dichlorobenzene is an
isomer of 1,2-dichlorobenzene and is non-toxic at low
and mid doses. Since each compound has its unique
chemical structure and properties, the activated biological
processes, molecular pathways, type of toxicity in the liver
and injury could be highly similar or dissimilar. Consid-
ering these variables, we partitioned the columns of the
gene expression data matrix (Additional file 2) into eight
groups (one for each chemical) for analysis using cc-
Biclustering (Additional file 3). The number of samples in
each group varied from 32 to 72. The data is publicly
available at the Gene Expression Omnibus (GEO) data-
base http://www.ncbi.nlm.nih.gov/geo/ under series
GSE15785 and at the Chemical Effects in Biological Sys-
tems (CEBS) database http://cebs.niehs.nih.gov under
accession number 001-00001-0020-000-4.
Clinical chemistry
At sacrifice, blood was collected into serum separation
tubes (BD Microtainer® Tubes, BD, Franklin Lakes, NJ)
Heat maps of two biclusters containing all samples and genes  unconstrained by ALT Figure 3
Heat maps of two biclusters containing all samples 
and genes unconstrained by ALT. (A) 330 co-expressed 
genes are up-regulated in the top half; (B) 409 co-expressed 
genes are down-regulated in the bottom half. The samples 
are ordered the same as in Figure 1.BMC Genomics 2009, 10:272 http://www.biomedcentral.com/1471-2164/10/272
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and serum was separated. Clinical chemistry analyses of
alanine aminotransferase (ALT) was performed on all rats
at study termination. Serum levels of the established liver
injury marker ALT (Additional file 4) increase when the
liver shows inflammation, injury or hepatotoxicity.
cc-Biclustering
Rather than obtaining coherent measures across the
whole vector of gene expression, cc-Biclustering uses the
sample information in the study design of the experiment
to partition the M columns into J groups according to a
given phenotypic response or biological study of interest.
For instance, as shown in the next section where an
expression matrix has eight different chemicals, each
group corresponds to a chemical with which samples
(biological replicates included) are treated at different
doses and time points. A gene expression value of an ele-
ment in matrix A now has four indices, i.e.
Table 6: Significant biological processes and pathways discerning isomers and from an early toxic response
Identifier Term p-value
Up-regulated
GO:0009611 response to wounding 5.10E-05
GO:0001525 angiogenesis 6.07E-04
GO:0002376 immune system process 1.29E-03
GO:0009605 response to external stimulus 1.33E-03
GO:0007596 blood coagulation 3.19E-03
GO:0042730 fibrinolysis 3.56E-03
GO:0006954 inflammatory response 3.96E-03
GO:0030595 leukocyte chemotaxis 4.83E-03
GO:0006935 chemotaxis 4.94E-03
GO:0030195 negative regulation of blood coagulation 6.00E-03
GO:0006873 cellular ion homeostasis 6.72E-03
GO:0042127 regulation of cell proliferation 9.24E-03
rno04660 T cell receptor signaling pathway 2.91E-02
rno04810 Regulation of actin cytoskeleton 3.33E-02
rno04520 Adherens junction 4.58E-02
rno04620 Toll-like receptor signaling pathway 5.95E-02
Down-regulated
GO:0005975 carbohydrate metabolic process 1.89E-04
GO:0032787 monocarboxylic acid metabolic process 1.06E-03
GO:0005978 glycogen biosynthetic process 1.82E-03
GO:0006066 alcohol metabolic process 2.09E-03
GO:0000271 polysaccharide biosynthetic process 5.09E-03
GO:0019318 hexose metabolic process 5.68E-03
GO:0042593 glucose homeostasis 6.71E-03
GO:0019752 carboxylic acid metabolic process 8.06E-03
GO:0006094 gluconeogenesis 8.54E-03
rno04910 Insulin signaling pathway 4.10E-02
rno00030 Pentose phosphate pathway 9.79E-02
Early response
GO:0006469 negative regulation of protein kinase activity 3.82E-06
GO:0016070 RNA metabolic process 3.88E-04
GO:0006355 regulation of transcription, DNA-dependent 4.35E-04
GO:0012501 programmed cell death 6.37E-04
GO:0032774 RNA biosynthetic process 7.12E-04
GO:0031323 regulation of cellular metabolic process 1.27E-03
GO:0045941 positive regulation of transcription 4.03E-03
GO:0030154 cell differentiation 5.41E-03
GO:0006366 transcription from RNA polymerase II promoter 9.35E-03
rno04010 MAPK signaling pathway 2.17E-04
rno04012 ErbB signaling pathway 2.60E-02
rno04912 GnRH signaling pathway 2.67E-02BMC Genomics 2009, 10:272 http://www.biomedcentral.com/1471-2164/10/272
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where row index i is from 1 to N number of genes; the col-
umn index breaks up into three sub-indices, j, k, and l. The
index j is from 1 to J number of groups (i.e., each of the
groups corresponds to a chemical). The index k is from 1 to
K number of treatments within a group (i.e., corresponding
to a given chemical, a treatment is exposure to a given dose
at a given time point). The index l is from 1 to L, where L is
the number of biological replicates. The general idea of cc-
Biclustering is to map matrix A to a binary coherent matrix
H(hi, j) according to an inclusion\exclusion criterion func-
tion. The H matrix has N rows and J columns.
The advantages of bracketing samples or conditions into a
set of groups are four-fold. (1) A coherent measure of
expression is computed within a group to determine if a
gene aij is included in a bicluster, where aij is a vector of
expression values of ith row and jth group. (2) Gene expres-
sion aij can be time and/or dose series derived. If there
were several replicates at a given time and dose, aij is eval-
uated to determine if it is differentially expressed and
should be included in a bicluster. (3) The coherent meas-
ure (CM) used between pairs of gene vectors ai1,j and ai2,j
(or phenotypic profile Sj) is flexible. Depending on a
research interest, CM can be chosen to be Pearson correla-
tion, Euclidean distance, or some other measure of bio-
logically relevant similarity. (4) The cc-Biclustering
algorithm is simple. Like many coherent value based
models (such as an additive model, multiplicative model
or based on a given CM) cc-Biclustering converts a gene
expression matrix A to a binary matrix H with a given p-
value threshold. The extracted biclusters then have con-
stant rows and columns [15]. We used the DAVID data-
base (April 2008 version) for Gene Ontology (January
2008 download) biological processes and KEGG pathway
(January 2008 download) analyses of the genes within the
biclusters and used p-values for over-representation of
these biological categories based on a one-tailed Fisher
exact probability or EASE score [32]. The supervised and
unsupervised cc-Biclustering algorithms are described in
more detail and depicted in pseudo code (Additional file
1). A comparison of the analysis of a microarray gene
expression data set from Arabidopsis thaliana samples
treated with various conditions and times of exposure
using unsupervised cc-Biclustering and the Cheng and
Church biclustering algorithm [33] with parameters δ =
0.5, α = 1.2 and output = 10 biclusters revealed that our
method produced the top 3 biclusters of genes (by size)
which are highly correlated within the subset of samples
that shared similar exposure conditions with a Pearson
correlation in the range of +0.73 to +0.84 whereas the
other method produced the top 3 biclusters of genes with
correlation in the range of +0.01 to +0.55.
Authors' contributions
JWC and PRB designed the strategy of cc-Biclustering. JWC
implemented the cc-Biclustering algorithm, analyzed the
data and wrote part of the manuscript. PRB provided sug-
gestions, advice and guidance for the concept of the
research, interpreted the results and also wrote part of the
manuscript. The authors have read and approved the final
manuscript.
Additional material
aijkl ,,, (1)
Additional file 1
Supervised and unsupervised cc-Biclustering details, pseudo code and 
supplemental figures and table.
Click here for file
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Heat maps of three biclusters containing genes discerning  isomers or depicting an early response to the toxic exposure Figure 4
Heat maps of three biclusters containing genes dis-
cerning isomers or depicting an early response to the 
toxic exposure. (A) 175 co-expressed genes are up-regu-
lated (top); (B) 114 co-expressed genes are down-regulated 
(middle). (C) 47 co-expressed were up-regulated (bottom). 
The samples are ordered the same as in Figure 2.BMC Genomics 2009, 10:272 http://www.biomedcentral.com/1471-2164/10/272
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